Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.

Gamal ShihaReham Soliman Nabiel N H MikhailKhalid AlswatAyman AbdoFaisal SanaiMoutaz F Derbala Necati ÖrmeciGeorge N DalekosSaid Al-BusafiWaseem HamoudiAla I ShararaSamy ZakyFathiya El-RaeyMai MabroukSamir MarzoukHidenori Toyoda

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)

FIB-6 score is a non-invasive, simple, and accurate test for ruling out liver cirrhosis and compensated advance liver disease in patients with chronic hepatitis C and performs better than APRI, FIB-4, and AAR.

Keyphrases

liver fibrosis
machine learning
artificial intelligence
high resolution
cross sectional
clinical trial
big data
mass spectrometry
drug induced